Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center
Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh
Korean J Hepatol. 2011;17(2):113-119. Published online 2011 Jun 23 DOI: https://doi.org/10.3350/kjhep.2011.17.2.113
|
Citations to this article as recorded by
Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China
Yun-Wei Yan, Xin-Kui Liu, Shun-Xiang Zhang, Qing-Feng Tian
World Journal of Gastrointestinal Oncology.2023; 15(5): 858. CrossRef Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China
Yun-Wei Yan, Xin-Kui Liu, Shun-Xiang Zhang, Qing-Feng Tian
World Journal of Gastrointestinal Oncology.2023; 15(5): 859. CrossRef The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival
Ashish Manne, Madhuri Mulekar, Daisy Escobar, Pranitha Prodduturvar, Yazan Fahmawi, Phillip Henderson, Osama Abdul-Rahim, Zeiad Hussain, Spencer Liles, Annabelle Fonseca, John Harrison Howard, Wadad Mneimneh, Robert Gilbert, Omar Alkharabsheh, Sachin Pai,
Journal of Cancer Research and Therapeutics.2023; 19(5): 1103. CrossRef Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma
Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, Sun Gyo Lim, Min Jae Yang, Choong-Kyun Noh, Gil Ho Lee, Soon Sun Kim
World Journal of Gastroenterology.2023; 29(47): 6122. CrossRef Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study
He-tong Zhao, Yong-bin Meng, Xiao-feng Zhai, Bin-bin Cheng, Sha-sha Yu, Man Yao, Hui-xia Yin, Xu-ying Wan, Yun-ke Yang, Hui Liu, Feng Shen, Chang-quan Ling
Journal of Integrative Medicine.2020; 18(4): 319. CrossRef Combined extensive liver resections in patients with locally advanced hepatocellular cancer – clinical cases
D. V. Sidorov, M. V. Lozhkin, L. O. Petrov, A. G. Isaeva, M. S. Gusakova
Research and Practical Medicine Journal.2020; 7(2): 154. CrossRef Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines
Soumya Jogi, Radha Varanai, Sravani S. Bantu, Ashish Manne
Oncology Reviews.2020;[Epub] CrossRef Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment
Ah Ran Kim, Eugene Park, So Young Kwon, Seong Jun Park, Young Jung Kim, Byung Chul Yoo, Won Hyeok Choe, Jeong Han Kim, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi hye Yu, Hae jeong Jeon
The Korean Journal of Gastroenterology.2019; 73(3): 167. CrossRef Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina
Federico Piñero, Sebastián Marciano, Nora Fernández, Jorge Silva, Yanina Zambelo, Manuel Cobos, Alina Zerega, Ezequiel Ridruejo, Carlos Miguez, Beatriz Ameigeiras, Claudia D’Amico, Luis Gaite, Matías Coronel, Carla Bermúdez, Carlos Rosales, Gustavo Romero
European Journal of Gastroenterology & Hepatology.2018; 30(4): 376. CrossRef Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence
Ye Xin Koh, Hwee Leong Tan, Weng Kit Lye, Juinn Huar Kam, Adrian Kah Heng Chiow, Siong San Tan, Su Pin Choo, Alexander Yaw Fui Chung, Brian Kim Poh Goh
World Journal of Hepatology.2018; 10(6): 433. CrossRef Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
Luciana Kikuchi, Aline Lopes Chagas, Regiane S.S.M. Alencar, Claudia Tani, Marcio A. Diniz, Luiz A.C. D'Albuquerque, Flair José Carrilho
Clinics.2017; 72(8): 454. CrossRef Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru
Eloy Ruiz, Teresa Rojas Rojas, Francisco Berrospi, Ivan Chávez, Carlos Luque, Luis Cano, Franco Doimi, Pascal Pineau, Eric Deharo, Stéphane Bertani
Heliyon.2016; 2(1): e00052. CrossRef Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas
G-A Kim, J H Shim, M-J Kim, S Y Kim, H J Won, Y M Shin, P N Kim, K-H Kim, S-G Lee, H C Lee
Journal of British Surgery.2016; 103(1): 126. CrossRef Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea
Jeong-Min Lee, Myeong-Jin Kim, Sith Phongkitkarun, Abhasnee Sobhonslidsuk, Anke-Peggy Holtorf, Harald Rinde, Karsten Bergmann
Journal of Medical Economics.2016; 19(8): 759. CrossRef Use of18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
Min Jin Kim, Young Seok Kim, Youn Hee Cho, Hee Yoon Jang, Jeong-Yeop Song, Sae Hwan Lee, Soung Won Jeong, Sang Gyune Kim, Jae Young Jang, Hong Su Kim, Boo Sung Kim, Won Hyung Lee, Jung Mi Park, Jae Myung Lee, Min Hee Lee, Deuk Lin Choi
The Korean Journal of Internal Medicine.2015; 30(3): 308. CrossRef Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Gi-Ae Kim, Ju Hyun Shim, Sang Min Yoon, Jinhong Jung, Jong Hoon Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Yoon-Koo Kang, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Journal of Vascular and Interventional Radiology.2015; 26(3): 320. CrossRef Real Life Treatment of Hepatocellular Carcinoma: Impact of Deviation from Guidelines for Recommended Therapy
Alzhraa Alkhatib, Asmaa Gomaa, Naglaa Allam, Eman Rewisha, Imam Waked
Asian Pacific Journal of Cancer Prevention.2015; 16(16): 6929. CrossRef Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B
Seok Won Jung, Neung Hwa Park, Jung Woo Shin, Bo Ryung Park, Chang Jae Kim, Jong-Eun Lee, Eun-Soon Shin, Jeong A Kim, Young-Hwa Chung
Hepatology.2014; 59(5): 1912. CrossRef Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and in the postoperative period: A cause for concern
Ser Yee Lee, Michael A. Mooney, Matthew L. Inra, Krishna Juluru, Alyson N. Fox, Sonja K. Olsen, Robert S. Brown, Jean C. Emond, Daniel Cherqui, Michael D. Kluger
Hepatology.2014; 59(2): 496. CrossRef Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group
Simona Leoni, Fabio Piscaglia, Ilaria Serio, Eleonora Terzi, Irene Pettinari, Luca Croci, Sara Marinelli, Francesca Benevento, Rita Golfieri, Luigi Bolondi
Digestive and Liver Disease.2014; 46(6): 549. CrossRef Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study
Hao Hu, Zhenhua Duan, Xiaoran Long, Yancu Hertzanu, Haibin Shi, Sheng Liu, Zhengqiang Yang, Gayle E. Woloschak
PLoS ONE.2014; 9(5): e96620. CrossRef Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
Gwang Hyeon Choi, Ju Hyun Shim, Min-Joo Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Yoon-Koo Kang, Yong Moon Shin, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
Radiology.2013; 269(2): 603. CrossRef Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
Jian-Hong Zhong, Bang-De Xiang, Wen-Feng Gong, Yang Ke, Qin-Guo Mo, Liang Ma, Xing Liu, Le-Qun Li, Matias A. Avila
PLoS ONE.2013; 8(7): e68193. CrossRef Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
Gwang Hyeon Choi, Ju Hyun Shim, Min-Joo Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Yoon-Koo Kang, Yong Moon Shin, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
Radiology.2013; 269(2): 603. CrossRef Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: Possible implications on survival
Seok Won Jung, Neung Hwa Park, Jung Woo Shin, Bo Ryung Park, Chang Jae Kim, Jong-Eun Lee, Eun-Soon Shin, Jeong A Kim, Young-Hwa Chung
Journal of Hepatology.2012; 57(3): 621. CrossRef
|